|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
1
|
|
pubmed:dateCreated |
1997-3-10
|
|
pubmed:abstractText |
Cholangiocarcinoma is rare but carries a poor prognosis. Radiotherapy has been used either as an adjuvant treatment following surgical resection of tumour or for palliation. The purpose of this study was to assess the feasibility and morbidity of accelerated external beam radiotherapy with or without intraluminal radiotherapy in the treatment of locally advanced bile duct cancer.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Oct
|
|
pubmed:issn |
0167-8140
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
41
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
61-6
|
|
pubmed:dateRevised |
2004-11-17
|
|
pubmed:meshHeading |
pubmed-meshheading:8961369-Bile Duct Neoplasms,
pubmed-meshheading:8961369-Bile Ducts, Extrahepatic,
pubmed-meshheading:8961369-Brachytherapy,
pubmed-meshheading:8961369-Cholangiocarcinoma,
pubmed-meshheading:8961369-Feasibility Studies,
pubmed-meshheading:8961369-Female,
pubmed-meshheading:8961369-Humans,
pubmed-meshheading:8961369-Iridium Radioisotopes,
pubmed-meshheading:8961369-Male,
pubmed-meshheading:8961369-Middle Aged,
pubmed-meshheading:8961369-Radiotherapy, High-Energy,
pubmed-meshheading:8961369-Survival Rate,
pubmed-meshheading:8961369-Time Factors
|
|
pubmed:year |
1996
|
|
pubmed:articleTitle |
External beam and intraluminal radiotherapy for locally advanced bile duct cancer: role and tolerability.
|
|
pubmed:affiliation |
Department of Clinical Oncology, Hammersmith Hospital, London, UK.
|
|
pubmed:publicationType |
Journal Article
|
